Work

Broadening Degrader Therapeutics: Keap1 PROTACs, Antimalarial Hybrids, and PLK1 Inhibition of NLRP3 Inflammasomes

Year: 2025

Type: editorial

Source: ACS Medicinal Chemistry Letters

DOI: 10.1021/acsmedchemlett.5c00596

Authors: Anna C. Renner, Robert B. Kargbo

Institutions: North Dakota State University, Usona Institute

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415030706

Cites: 6

Cited by:

Related to: